Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery

被引:82
|
作者
Kheterpal, Sachin [1 ]
Khodaparast, Omeed [2 ]
Shanks, Amy [1 ]
O'Reilly, Michael [1 ]
Tremper, Kevin K. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48103 USA
[2] Baylor Univ, Med Ctr, Dept Anesthesiol, Dallas, TX 75246 USA
关键词
angiotensin-converting enzyme inhibitor; intraoperative hypotension; diuretics;
D O I
10.1053/j.jvca.2007.12.020
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: Chronic angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) therapy has been reported to result in intraoperative hypotension in patients undergoing general anesthesia. This study evaluated the association between ACE-I/ARB therapy and the hemodynamics of patients undergoing noncardiac surgery using a large patient dataset. Design and Setting: A prospective, observational study performed at a single tertiary care hospital. Participants: All adult patients undergoing noncardiac surgery. Interventions: None. Measurements and Main Results: Propensity score matching for the likelihood of chronic ACE-I/ARB therapy was used to create 2 patient cohorts with similar cardiovascular and pulmonary comorbidities. The number of periods of absolute and relative hypotension, vasopressor requirements, and postoperative myocardial infarction and renal failure rates were compared among patients with and without ACE-I/ARB therapy. A total of 65,043 noncardiac cases be-tween 2003 and 2006 were included. Two-digit propensity score matching resulted in a study population of 12,381 operative cases with very similar cardiovascular comorbidities between the ACE-I/ARB and control cohort. Patients with chronic ACE-I/ARB and diuretic therapy showed more periods with a mean arterial pressure <70 mmHg, periods with a 40% decrease in systolic blood pressure, periods with a 50% decrease in systolic blood pressure, and vasopressor boluses when compared with patients with diuretic therapy alone. There were no statistically significant differences in the rates of postoperative myocardial infarction or renal failure between patients with and without ACE-I/ARB therapy. Conclusions: Chronic diuretic therapy is associated with more frequent hypotension in ACE-I/ARB-treated patients undergoing noncardiac surgery. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 50 条
  • [1] Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure
    Struckman, DR
    Rivey, MP
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 242 - 248
  • [2] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [3] THE ANTIPROTEINURIC EFFECT OF COMBINED ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKER THERAPY IN PRIMARY GLOMERULONEPHRITIS
    Kaptanogullari, Ozlem Harmankaya
    Ozbahar, Yalcin
    Cecen, Ismail
    Kaptanogullari, Hakan
    NEPHROLOGY, 2005, 10 : A168 - A168
  • [4] ANTIPROTEINURIC AND RENOPROTECTIVE EFFECTS OF COMBINATION THERAPY WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND AN ANGIOTENSIN RECEPTOR BLOCKER
    Sadiku, Edita
    Idrizi, Alma
    Gjata, Margarita
    Barbullushi, Myftar
    Hoti, Klit
    Tase, Mihal
    Koroshi, Alketa
    NEPHROLOGY, 2005, 10 : A136 - A136
  • [5] Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions
    Carlson, Geoffrey S.
    Wong, Priscilla H.
    White, Kevin M.
    Quinn, James M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (05): : 1430 - 1432
  • [6] COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy
    Kussmaul, William G., III
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (03) : 237 - 238
  • [7] Vascular protective effects of combined therapy of angiotensin receptor blocker and angiotensin-converting enzyme inhibitor in essential hypertension.
    Morimoto, Satoshi
    Tokoro, Toshiko
    Kikuchi, Sanae
    Yamahara, Hideki
    Imada, Takanobu
    Kohno, Keiko
    Masaki, Hiroya
    Takahashi, Nobuyuki
    Nishikawa, Mitsushige
    Iwasaka, Toshiji
    JOURNAL OF HYPERTENSION, 2006, 24 : 190 - 190
  • [8] Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats
    Yamada, T
    Kuno, A
    Ogawa, K
    Tang, MX
    Masuda, K
    Nakamura, S
    Ando, T
    Okamoto, T
    Ohara, H
    Nomura, T
    Joh, T
    Shirai, T
    Itoh, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (01): : 36 - 45
  • [9] Cough in Pediatric Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy or Angiotensin Receptor Blocker Therapy in Randomized Controlled Trials
    Baker-Smith, C. M.
    Benjamin, D. K., Jr.
    Califf, R. M.
    Murphy, M. D.
    Li, J. S.
    Smith, P. B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (06) : 668 - 671
  • [10] Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure
    Carson, PE
    AMERICAN HEART JOURNAL, 2000, 140 (03) : 361 - 366